Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 20, 1991 - Issue 3
9
Views
4
CrossRef citations to date
0
Altmetric
Original Article

High Susceptibility of Cataract Shionogi (CTS) Mice to Passive Anaphylactic Shock Mediated by Allogeneic IgE and IgG1 Monoclonal Antibodies

, , &
Pages 305-315 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shigeru Kimura, Akira Watanabe, Mitsuo Takeuchi, Masafumi Nagata & Minoru Harada. (1998) Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum. Immunological Investigations 27:6, pages 379-393.
Read now

Articles from other publishers (3)

Lut Overbergh, Brigitte Decallonne, Dumitru D. Branisteanu, Dirk Valckx, Ahmad Kasran, Roger Bouillon & Chantal Mathieu. (2003) Acute Shock Induced by Antigen Vaccination in NOD Mice. Diabetes 52:2, pages 335-341.
Crossref
O'donnell & Openshaw. (2001) Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clinical & Experimental Allergy 28:12, pages 1501-1508.
Crossref
Akinori Arimura & Minoru Harada. (1991) Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains. Lipids 26:12, pages 1386-1390.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.